Printer Friendly

Browse Tumor markers topic


1-85 out of 85 article(s)
Title Author Type Date Words
Effect of Sintilimab combined with Chemotherapy on Tumor Markers and Immune Function of advanced non-small cell lung cancer. Xiaoyan Liang and Zhangfeng Wei Jun 4, 2021 2832
The Investigation of Treatment Effects on Serum Biochemical Parameters in Bladder Cancer Diseases. Ucer, Oktay; Kosova, Funda; Temeltas, Gokhan; Abusoglu, Sedat; Unlu, Ali; Dincel, Aylin Sepici; An, Report Jun 1, 2021 3057
Prognostic potential of CK-19 managing disseminated oral squamous cell carcinomas in Pakistan: A descriptive cross-sectional study. Iqbal, Waqas; Tariq, Uzma; Surwaich, Arhama; Chana, Surwaich Ali; Majid, Abdul; Ali, Shan; Bukhari, Report Mar 31, 2021 2574
Asia-Pacific Tumor Markers Sales Segment Forecasts for over 40 Tests: A 17 Country Report. Report Dec 18, 2019 667
France Tumor Markers Sales Segment Forecasts for over 40 Tests - 2019. Dec 16, 2019 677
2019 U.K. Tumor Markers Sales Segment Forecasts for over 40 Tests: Abbott, DiaSorin, Hologic & OncoLab. Dec 16, 2019 683
Italy Tumor Markers Sales Segment Forecasts for over 40 Tests: 2019. Dec 16, 2019 677
Latin America Tumor Markers Sales Segment Forecasts for Over 4o Tests: A 7-Country Analysis. Dec 13, 2019 665
Global Cancer Diagnostics Market Report 2019: Emerging Opportunities, Supplier Shares, Strategies, Latest Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation. Report Dec 10, 2019 718
World Tumor Markers Sales Forecasts 2019-2024: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Tests, Technologies and Opportunities. Dec 10, 2019 633
Europe Tumor Markers Sales Segment Forecasts for 40+ Tests: 2019 31-Country Analysis. Dec 10, 2019 640
United States Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers 2019: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review. Nov 6, 2019 316
North America Tumor Markers Sales Segment Forecasts Report 2019. Report Oct 24, 2019 639
Kenya Clinical Chemistry & Immunodiagnostic Markets, 2018-2023: Volume & Sales Segment Forecasts for Routine & Special Chemistries, Endocrine Function, Immunoproteins, TDM, and Tumor Markers. Oct 15, 2019 554
Ovarian tumor markers: What to draw and when. Rossi, Emma Oct 1, 2019 1513
Kris Aquino gives update on her health, says tests for tumor markers were negative. Oct 2, 2018 332
The Impact of Subtype Distribution in Inflammatory Breast Cancer Outcome. Cakar, Burcu; Surmeli, Zeki; Oner, Pinar Gursoy; Yelim, Elif Sila; Karabulut, Bulent; Uslu, Ruchan Report Oct 1, 2018 4830
Kris Aquino on Singapore trip: Tests for tumor markers 'negative'. Oct 1, 2018 142
THYROGLOBULIN AS A TUMOR MARKER IN DIFFERENTIATED THYROID CANCER--CLINICAL CONSIDERATIONS. Prpic, Marin; Franceschi, Maja; Romic, Matija; Jukic, Tomislav; Kusic, Zvonko Report Sep 1, 2018 6819
A comparative study of p53 expression in premalignant and malignant cervical lesions at a tertiary care institute of Rohilkhand region, India. Yadav, Vinay; Jaiswal, Milan; Pandey, Surabhi Report Mar 1, 2018 4219
Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer. Chen, Zhong-qing; Huang, Ling-sha; Zhu, Bo Jan 1, 2018 4993
Current Status of Histologic Grading in Prostate Carcinoma and Renal Cell Carcinoma / Prostat Karsinomu ve Renal Hucreli Karsinoma Histolojik Derecelemesinde Son Durum. Kankaya, Duygu Report Jun 1, 2017 1665
A study of total sialic acid and lipid bound sialic acid levels and total sialic acid to total protein ratio in cancer patients. Tummalacharla, Sarat Chandan; Meenakshi, Gonella Geetha Report Mar 16, 2017 3833
The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung Cancer. Liu, Linjie; Teng, Jinlong; Zhang, Lijun; Cong, Peishan; Yao, Yuan; Sun, Guirong; Liu, Zhijun; Yu, T Report Jan 1, 2017 5584
Colorectal Cancer Blood-Based Biomarkers. Hauptman, Nina; Glavac, Damjan Report Jan 1, 2017 9416
A Review of the Role of Neurotensin and Its Receptors in Colorectal Cancer. Qiu, Shengyang; Pellino, Gianluca; Fiorentino, Francesca; Rasheed, Shahnawaz; Darzi, Ara; Tekkis, Pa Report Jan 1, 2017 5934
Polymorphisms in lncRNA PTENP1 and the Risk of Gastric Cancer in a Chinese Population. Ge, Yugang; He, Yu; Jiang, Mingkun; Luo, Dakui; Huan, Xiangkun; Wang, Weizhi; Zhang, Diancai; Yang, Report Jan 1, 2017 6168
Evaluation of HE4, CA-125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) in the preoperative assessment of patients with adnexal mass. Musalhi, Khawla Al; Kindi, Manal Al; Aisary, Faiza Al; Ramadhan, Fatma; Rawahi, Thuraya Al; Hatali, Report Sep 1, 2016 5543
Robert Weinberg, MIT, to Present at 2nd Cancer Markers & Liquid Biopsies. Jun 1, 2016 362
Paraskevi Giannakakou, Weill-Cornell Medical College to Present at 2nd Cancer Markers & Liquid Biopsies. May 30, 2016 477
Johan Skog, CSO at Exosomes Diagnostics to Present at 2nd Cancer Markers & Liquid Biopsies. May 7, 2016 367
Rebecca Leary, Novartis, to Present at 2nd Cancer Markers & Liquid Biopsies. Apr 29, 2016 277
Helmy Eltoukhy, Guardant Health, to Give Keynote at 2nd Cancer Markers & Liquid Biopsies. Apr 27, 2016 529
New Markers for Separating Benign From Malignant Mesothelial Proliferations Are We There Yet? Churg, Andrew; Sheffield, Brandon S.; Galateau-Salle, Francoise Report Apr 1, 2016 4096
Emerging roles of SPINK1 in cancer. Rasanen, Kati; Itkonen, Outi; Koistinen, Hannu; Stenman, Ulf-Hakan Report Mar 1, 2016 7337
Clinical Value of Tumor Markers for Determining Cause of Pleural Effusion. Gu, Yan; Zhai, Kan; Shi, Huan-Zhong Report Mar 1, 2016 3144
Elevated serum CA 19-9 levels in patients with pulmonary nontuberculous mycobacterial disease. Hong, Ji Young; Jang, Sun Hee; Kim, Song Yee; Chung, Kyung Soo; Song, Joo Han; Park, Moo Suk; Kim, Y Report Jan 1, 2016 4445
Pancreatico duodenal neuroendocrine tumours--our experience over the past 2 years. Naik, Balakrishna M.; Girish, G.; Harish, K.; Kiran, Kailas C. Report Jan 29, 2015 1842
Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. Lucarelli, Giuseppe; Ditonno, Pasquale; Bettocchi, Carlo; Vavallo, Antonio; Rutigliano, Monica; Gall Clinical report Jan 1, 2014 4247
Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of Canada. Organ, Michael; Jewett, Michael; Basiuk, Joan; Morash, Christopher; Pautler, Stephen; Siemens, D. Ro Clinical report Jan 1, 2014 3017
Soluble thyroid tumor markers--old and new challenges and potential solutions. Grebe, Stefan K.G. Report Nov 1, 2013 11140
Lung cancer biomarkers: present status and future developments. Cagle, Philip T.; Allen, Timothy Craig; Olsen, Randall J. Report Sep 1, 2013 8804
Ttf-1 and napsin a do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas.: Proposal of a Novel Staining Panel. Aulakh, Kanwaijit S.; Chisholm, Cary D.; Smith, Daniel A.; Speights, V.O. Report Aug 1, 2013 3427
A pilot study of urinary microRNA as a biomarker for urothelial cancer. Snowdon, Jaime; Boag, Sandy; Feilotter, Harriet; Izard, Jason; Siemens, D. Robert Report Feb 1, 2013 3329
Bladder cancer: Validating what we've got. Zlotta, Alexandre R. Report Feb 1, 2013 1271
Design of tumor biomarker-monitoring trials: a proposal by the European Group on Tumor Markers. Soletormos, Gyorgy; Duffy, Michael J.; Hayes, Daniel F.; Sturgeon, Catharine M.; Barak, Vivian; Boss Report Jan 1, 2013 5537
Regulation effect of zinc fingers and homeoboxes 2 on alpha-fetoprotein in human hepatocellular carcinoma. Hu, Shao Wei; Zhang, Meng; Xue, Ling; Wen, Jian Ming Report Jan 1, 2013 3809
Serum total homocysteine increases with the rapid proliferation rate of tumor cells and decline upon cell death: a potential new tumor marker. Brief article Dec 1, 2012 204
Eurycomanone suppresses expression of lung cancer cell tumor markers, prohibition, annexin 1 and endoplasmic reticulum protein 28. Wong, Pooi-Fong; Cheong, Wei-Fun; Shub, Meng-Hooi; Teh, Chin-Hoe; Chan, Kit-Lam; AbuBakarb, Sazaly Report Feb 15, 2012 5967
Are tumour markers requested appropriately: a one-month audit of tumour marker requests at Hawke's Bay District Health Board laboratory. Leverett, Sandy Nov 1, 2011 2323
3.4 kb mitochondrial genome deletion serves as a surrogate predictive biomarker for prostate cancer in histopathologically benign biopsy cores. Reguly, Brian; Jakupciak, John P.; Parr, Ryan L. Case study Oct 1, 2010 3740
The Cancer Profile and its clinical applications. Schandl, Emil K. Report Aug 1, 2010 2460
Cancer biomarkers--current perspectives. Bhatt, Anant Narayan; Mathur, Rohit; Farooque, Abdullah; Verma, Amit; Dwarakanath, B.S. Report Aug 1, 2010 15825
Growth rate of tumors calculation improved. McBride, Deborah Brief article May 1, 2010 266
Personalized medicine in advanced urothelial cancer: when to treat, how to treat and who to treat. Ehdaie, Behfar; Smith, Steven C.; Theodorescu, Dan Report Dec 1, 2009 4391
Ectopic expression of sortilin 1 (NTR-3) in patients with ovarian carcinoma. Hemmati, Shayda; Zarnani, Amir Hassan; Mahmoudi, Ahmad Reza; Sadeghi, Mohammad-Reza; Soltanghoraee, Report Jul 1, 2009 3298
Noncoding RNAs and cancer. Naeini, Mozhgan Moslemi; Ardekani, Ali M. Report Jul 1, 2009 9013
Symptoms of ovarian cancer reported in primary care are non-specific, UK. Brief article May 1, 2009 390
CA 125 plus ultrasound detects early ovarian Ca. Sullivan, Michele G. Report May 1, 2009 755
A history lesson in insurance screening: a cancer marker being proposed for screening life insurance applicants could be a wolf in sheep's clothing. George, Hank Sep 1, 2008 502
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements. Sturgeon, Catharine M.; Hoffman, Barry R.; Chan, Daniel W.; Ch'ng, Soo-Ling; Hammond, Elizabeth; Hay Clinical report Aug 1, 2008 6815
Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy. Capdevila, Jaume; Tabernero, Josep; Kohne, Claus-Henning Mar 1, 2008 1444
Hemangiomas and angiosarcomas of the breast: diagnostic utility of cell cycle markers with emphasis on Ki-67. Shin, Sandra J.; Lesser, Martin; Rosen, Paul Peter Clinical report Apr 1, 2007 3553
Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium. Sardana, Girish; Marshall, John; Diamandis, Eleftherios P. Mar 1, 2007 5552
New immunohistochemical markers in the evaluation of central nervous system tumors: a review of 7 selected adult and pediatric brain tumors. Takei, Hidehiro; Bhattacharjee, Meenakshi B.; Rivera, Andreana; Dancer, Yeongju; Powell, Suzanne Z. Clinical report Feb 1, 2007 8620
Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendroglioma. Aldape, Kenneth; Burger, Peter C.; Perry, Arie Clinical report Feb 1, 2007 6408
Prognostic significance of CD44, platelet-derived growth factor receptor [alpha], and cyclooxygenase 2 expression in renal cell carcinoma. Tawfik, Ossama W.; Kramer, Brandan; Shideler, Barbara; Danley, Marsha; Kimler, Bruce F.; Holzbeierle Clinical report Feb 1, 2007 4784
Overexpression of CD24: association with invasiveness in urothelial carcinoma of the bladder. Choi, Yoon-La; Lee, Seung-Hyun; Kwon, Ghee-Young; Park, Cheol-Keun; Han, Jae-Joon; Choi, Jong Sun; C Clinical report Feb 1, 2007 3636
Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas. Roma, Andres A.; Magi-Galluzzi, Cristina; Zhou, Ming Clinical report Jan 1, 2007 3349
Good early results for ovarian CA test. Bates, Betsy Apr 1, 2006 680
Biological variation of tumor markers and its application in the detection of disease progression in patients with non-small cell lung cancer. Trape, Jaume; de Olaguer, Joaquim Perez; Buxo, Josep; Lopez, Laura Jan 1, 2005 2810
Part II: Tumor markers from A to Z. Plaut, David Nov 1, 2004 2460
Part I: tumor markers from A to Z. Plaut, David Sep 1, 2004 2092
Criteria for tumor marker evaluation and utilization. (Cover Story). Fleisher, Martin Apr 1, 2003 2046
A comparative study of four serological tumor markers for the detection of breast cancer. Hall, Margot Apr 1, 2002 4165
An Immunostaining Panel for Diagnosis of Malignancy in Mucinous Tumors of the Pancreas. Zhao, Jin; Liang, Sharon X.; Savas, Lou; Banner, Barbara F. Jun 1, 2001 3302
Designing Tumor Marker Studies. Hayes, Daniel F. Jul 1, 2000 2477
Statistical Issues in Tumor Marker Studies. Pajak, Thomas F.; Clark, Gary M.; Sargent, Daniel J.; McShane, Lisa M.; Hammond, M. Elizabeth H. Statistical Data Included Jul 1, 2000 3660
Tumor cells make debut on television. Brief Article Oct 30, 1999 186
Antigen Sniffs Out Melanoma. Branch, David R. May 15, 1999 278
Stability of tumor markers CA 19.9, CA 125, and CA 15.3 in serum obtained from plain tubes and tubes containing thixotropic gel separator. Banfi, Giuseppe; Parma, Pierangela; Pontillo, Marina Dec 1, 1997 1337
Tumor markers: testing for cancer. Statland, Bernard E. Cover Story Jul 1, 1997 4870
Enzyme rare in adults may signal cancers. Seppa, Nathan Brief Article May 31, 1997 577
Prevalence of abnormal levels of serum tumour markers in elderly people. Lopez, Luis A.; Del Villar, Valentin; Ulla, Mariano; Fernandez, Francisco; Fernandez, Luis A.; Santo Jan 1, 1996 4341
Researchers discover a new tumor marker. Jul 1, 1990 233

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |